✦ LIBER ✦

P-204: Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor ZT-1 after repeated monthly subcutaneous administration of sustained-release implants in healthy volunteers

✍ Scribed by Emmanuel Tamchès; Geneviève Decosterd; François Burger; Laurent Bauduin; Annick Ménétrey; Valérie Nicolas; Hervé Claude Porchet; Piétro Scalfaro

Book ID: 118463207
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 46 KB
Volume: 3
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2007.04.109

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and bioavailability of

Pharmacokinetics and bioavailability of a sustained-release diltiazem formulation (Mono-Tildiem LP 300 mg) after repeated administration in healthy volunteers

✍ G. Bianchetti; C. Dubruc; P. Rosenzweig; V. Sultana; G. Houin 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 580 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of a slow-release formulation of diltiazem after the administration of a single and repeated doses to healthy volunteers

✍ M. Lefebvre; Y. Lacasse; J. Spénard; D. Geadah; R. Moisan; D. Gossard; H. Landri 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 782 KB

Diltiazem is a calcium antagonist used in angina pectoris and hypertension. There is little information concerning the slow-release (SR) formulation in the literature. The pharmacokinetics of diltiazem SR (120 mg) have been assessed over a 36 h period in healthy volunteers after single-(SD) and mult

The pharmacokinetics and pharmacodynamic

The pharmacokinetics and pharmacodynamics of metoprolol after conventional and controlled-release administration in combination with hydrochlorothiazide in healthy volunteers

✍ P. Lundborg; B. Abrahamsson; I. Wieselgren; M. Walter 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 302 KB

We have studied a controlled-release formulation containing metoprolol 100 mg and hydrochlorothiazide 12.5 mg. We compared the pharmacokinetics of both substances and the pharmacodynamics of metoprolol with those of a conventional combination tablet. The controlled-release formulation gave less vari